Actinium re-elects Class II directors Seth and Chell, ratifies Marcum as auditor at 2024 annual meeting

Actinium Pharmaceuticals, Inc.

Sandesh Seth and Jeffrey W. Chell re-elected as Class II directors for three-year terms expiring at 2027 annual meeting.
Marcum LLP ratified as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
Approximately 63.2% of outstanding shares (19.7M of 31.2M) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.